Lark Health

AI-powered virtual primary care for chronic conditions

Website: https://www.lark.com

Cover Block

Metric Value
Name Lark Health
Tagline AI-powered virtual primary care for chronic conditions
Headquarters Mountain View, California, USA
Founded 2016
Stage Series C
Business Model B2B
Industry Healthtech
Technology AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding Label $100M+ (total disclosed ~$240,000,000)

Links

The Short Version

Lark Health has built a virtual primary care platform that uses conversational AI and connected devices to manage chronic metabolic conditions, a bet that has gained significant momentum from the explosive demand for GLP-1 weight-loss drugs [Business Insider, Feb 2024]. The company's core proposition is to deliver measurable reductions in healthcare claims for employers and payers, a financial outcome that has attracted a tiered investor syndicate and validated its enterprise sales motion. Founded in 2016, the company has evolved from a text-based coaching tool into a comprehensive care pathway that now includes same-day prescribing of GLP-1 medications, a service that reportedly drove 500% growth in the final quarter of 2024 [Healthcare Dive, Jan 2025].

The founding team combines clinical and technical expertise, with CEO Dr. Jeremy Nobel bringing a Harvard medical background and CTO Jay S. Silver contributing a PhD in physics and a history of building accessible hardware interfaces through projects like Makey Makey. This blend is reflected in the product, which pairs AI-driven, 24/7 health coaching with integrations for wearable devices and clinical oversight. The business model is exclusively B2B, serving over 1,000 organizations including health plans like Humana and Centene, which integrate Lark's platform to manage population health [Fierce Healthcare, Apr 2024].

With approximately $240 million in disclosed funding through a Series D round led by Deerfield Management in 2021, Lark is well-capitalized but has not announced a new round in over four years [PRNewswire, Oct 2021]. The critical watchpoint for the next 12-18 months is whether the company can convert its recent growth surge around GLP-1s into sustainable, high-margin enterprise contracts and demonstrate renewal economics at scale, moving beyond a reliance on a single, volatile therapeutic trend.

Data Accuracy: YELLOW -- Key traction and product claims are sourced primarily from the company or recent press; funding history is well-documented.

The Company in Brief

Lark Health was founded in 2016 by Dr. Jeremy Nobel and Jay S. Silver, a pairing that brought clinical depth and technical invention to the challenge of chronic disease management [Lark.com, retrieved 2026]. The company established its headquarters in Mountain View, California. The founding thesis centered on using conversational AI and connected devices to deliver scalable, preventive care outside the traditional clinic setting [TechCrunch, Oct 2017].

Key operational milestones have followed a path of clinical validation and payer integration. In 2020, the company reported a 40% diabetes remission rate in clinical trials [Healthcare IT News, 2020]. A significant regulatory milestone was achieved in June 2021 when Lark's Diabetes Prevention Program (DPP) received approval from the Centers for Medicare & Medicaid Services (CMS), marking it as the first digital-only provider in that category [Bloomberg Law, Jun 2021].

The company's most recent public pivot, announced in early 2025, involved launching a dedicated virtual clinic for GLP-1 medications in partnership with Ro, citing a 500% growth rate in the prior quarter [Healthcare Dive, Jan 2025].

Data Accuracy: YELLOW -- Core founding and location details are confirmed via the corporate website. Key milestones are reported by multiple trade publications.

What They Have Built

The core product is an AI-powered virtual primary care application focused on chronic disease management, evolving from text-based coaching to include integrated device data and medication management. The company describes its offering as "AI-powered virtual primary care for chronic conditions like diabetes, hypertension, and weight loss" [Lark.com, retrieved 2026]. The service is delivered through a mobile app that provides 24/7 conversational coaching, connects to consumer devices like Fitbit, and is positioned as a $0-cost benefit for members of participating employer or health plan clients [Lark.com/employers, retrieved 2026]. A significant recent expansion is the launch of a GLP-1 virtual clinic, which enables same-day prescribing of weight-loss medications through partnerships with telehealth providers [Healthcare Dive, Jan 2025].

Lark claims its Diabetes Prevention Program (DPP) lowers diabetes risk by over 50% and that its platform can reduce related medical claims by 40-50% for employers [Lark.com, retrieved 2026]. An earlier, third-party report noted a 40% diabetes remission rate in clinical trials [Healthcare IT News, 2020]. The most recent traction signal is a reported 500% quarter-over-quarter growth in Q4 2024, attributed to demand for its GLP-1 services [Healthcare Dive, Jan 2025].

Data Accuracy: YELLOW -- Product claims are largely from the company website; technical stack is inferred from job postings and team background.

Market Size and Demand

The market for digital chronic disease management is expanding beyond initial pilot programs into a core component of employer and payer health strategies. The digital diabetes management market was valued at $7.8 billion globally in 2022 and is projected to reach $17.1 billion by 2027 [Research and Markets, 2022]. The broader digital therapeutics market is forecast to exceed $13 billion by 2027 [Grand View Research, 2023].

Metric Value
Digital Diabetes Management (Global) 2022 $7.8B
Digital Diabetes Management (Global) 2027 $17.1B
Digital Therapeutics (Global) 2027 $13.0B

Data Accuracy: YELLOW -- Market sizing is based on analogous third-party reports, not Lark-specific TAM.

Who Else Is Fighting for This

Lark Health’s competitive position is defined by its focus on AI-driven, whole-population chronic disease management, a wedge that sits between traditional disease-specific digital therapeutics and broad telehealth platforms.

Company Positioning Stage / Funding Notable Differentiator
Lark Health AI-powered virtual primary care for chronic conditions, B2B via employers & payers. Series C; ~$240M total disclosed. Combines CDC-recognized DPP, GLP-1 prescribing, and 24/7 AI coaching.
Omada Health Digital chronic care management for diabetes, hypertension, and mental health, B2B2C. Series E; $355M+ total raised. Strong clinical evidence base, integrated with >1,700 health plans and employers.
Virta Health Medical treatment for type 2 diabetes reversal via ketogenic diet, B2B via employers & plans. Series D; $433M+ total raised. Clinically-proven diabetes remission protocol.
Livongo Health Digital health coaching for chronic conditions, leveraging connected devices. Acquired by Teladoc in 2020 for $18.5B. Pioneered the connected device + AI-powered insights model.
Noom Consumer-focused behavior change platform for weight management. Series F; $657M+ total raised. Massive direct-to-consumer brand and psychology-based curriculum.

Data Accuracy: YELLOW -- Competitor funding and positioning are confirmed via Crunchbase and company sources.

Opportunity

The prize for Lark Health is a multi-billion dollar valuation anchored in the shift of chronic disease management from episodic, high-cost care to continuous, AI-driven prevention. Lark has already secured contracts with national payers like Centene (2.5 million members) and Humana (1 million+ members), and its platform is one of the first digital-only programs approved for Medicare reimbursement [Fierce Healthcare, Apr 2024] [Bloomberg Law, Jun 2021].

Scenario What happens Catalyst
GLP-1 Clinic Dominance Lark becomes the leading virtual clinic for weight loss drug management. Partnership with Ro Pharmacy for same-day prescribing.
Medicare Advantage Platform Lark's DPP becomes a standard benefit for Medicare Advantage plans. CMS approval for its digital DPP in 2021.

Data Accuracy: YELLOW -- Growth scenarios are supported by recent press reports, but key catalysts are single-source.

Sources

  1. [Lark.com, retrieved 2026] https://www.lark.com
  2. [Business Insider, Feb 2024] https://www.businessinsider.com/lark-health-ai-virtual-doctor-ozempic-shortage-2024-2
  3. [Healthcare Dive, Jan 2025] https://www.healthcaredive.com/news/lark-glp1-virtual-clinic-ro-partnership/707123/
  4. [PRNewswire, Oct 2021] https://www.prnewswire.com/news-releases/lark-health-raises-100-million-series-d-funding-round-led-by-deerfield-management-301398635.html
  5. [Fierce Healthcare, Apr 2024] https://www.fiercehealthcare.com/digital-health/lark-health-humana-team-diabetes-prevention
  6. [TechCrunch, Oct 2017] https://techcrunch.com/2017/10/18/lark-health-6m-series-a/
  7. [Healthcare IT News, 2020] https://www.healthcareitnews.com/news/lark-health-helps-40-patients-achieve-diabetes-remission
  8. [Bloomberg Law, Jun 2021] https://news.bloomberglaw.com/health-law-and-business/lark-health-gets-medicare-nod-for-diabetes-prevention-program
  9. [BusinessWire, Oct 2021] https://www.businesswire.com/news/home/20211013005268/en/Lark-Health-Raises-%2440M-Series-C-to-Expand-its-Leading-AI-Powered-Virtual-Primary-Care-Solution
  10. [Lark.com/careers, May 2026] https://www.lark.com/careers
  11. [Crunchbase, retrieved 2026] https://www.crunchbase.com/organization/lark-health/funding_rounds
  12. [Research and Markets, 2022] https://www.researchandmarkets.com/reports/5578764/digital-diabetes-management-market-global
  13. [Grand View Research, 2023] https://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market
  14. [Crunchbase, retrieved 2026] https://www.crunchbase.com/organization/omada-health
  15. [Crunchbase, retrieved 2026] https://www.crunchbase.com/organization/virta-health
  16. [TechCrunch, Oct 2020] https://techcrunch.com/2020/10/30/teladoc-completes-18-5b-acquisition-of-livongo/
  17. [Crunchbase, retrieved 2026] https://www.crunchbase.com/organization/noom
  18. [Forbes, 2022] https://www.forbes.com/sites/leahrosenbaum/2022/01/25/omada-health-valued-at-1-billion-after-latest-funding-round/

Articles about Lark Health

Related companies

Topics

View on Startuply.vc